Jetzt bei Plus500 CFDs auf die weltweit gefragtesten Basiswerte wie Aktien, Indizes oder Kryptowährungen entdecken!5 -W-
10.03.2005 20:46:00

CareScience to Host Healthcare Industry Leaders at 2005 National Confe

CareScience to Host Healthcare Industry Leaders at 2005 National Conference


    Business Editors/Health/Medical Writers
    CareScience 2005 National Conference

    PHILADELPHIA--(BUSINESS WIRE)--March 10, 2005--

    National Experts to Address Patient-Safety, Improving Healthcare
    Quality and Medical Errors Reduction at Leading-Quality
    Healthcare Conference

What: CareScience 2005 National Conference, "Quality in Motion: Achieving Success through Care Management Innovation." The CareScience 2005 National Conference will be organized around four key session tracks covering topics critical to quality, operational and financial initiatives, including:

-- Quality and Performance Improvement: Sessions will draw from the experience and success of colleagues and national leaders in translating data into meaningful information used by clinicians to improve care processes, reduce complications, improve compliance with evidence-based medicine and improve information handling.

-- Leadership & Strategy: This track will focus on interaction with industry leaders to learn how they drive their organizations to build the necessary environment for quality, and achieve significant clinical, operational and financial impact.

-- Pay for Performance: Sessions will discuss and evaluate the most common forms of incentives applied to date including Cost Differentials, Reduced Administrative Oversight and Overhead, Public Disclosure and Payment Differentials.

-- Patient Safety: This track will focus on the application of clinical outcomes data as well as other data that is linked to patient safety, quality and clinical results.

During the conference, CareScience will present the 2005 CareScience "Top Performer" awards to those facilities that demonstrated leadership and outstanding overall clinical outcomes in specific clinical care areas. The award recognizes care process and clinical outcomes as measured by quality and efficiency, including such metrics as complication rate, mortality and length-of-stay. The conference will provide an open environment for the discussion of industry growth, innovation, and achievement in the areas of quality and care management, regulatory and public reporting and patient safety.

Who: Attendees will include 200 - 250 healthcare industry executives, physician leaders, care managers and quality managers.

Featured speakers include:

-- Robert Wachter, MD, Professor, UCSF Medical Center

-- Carolyn M. Clancy, MD, Director, Agency for Healthcare Research and Quality (AHRQ)

-- Pamela Austin Thompson, MS, RN, FAAN, Chief Executive Officer, American Organization of Nurse Executives (AONE)

-- Bruce Fried, Esq, Sonnenschein, Nath, & Rosenthal LLP

-- John Latham, PhD, MBA, Managing Partner and Founder of Genitect, LLC

-- John Vinyard, Senior Partner and Founder of Genitect, LLC

-- Francois de Brantes, MBA, Program Leader, Healthcare Initiatives General Electric, Corporate Health Care & Medical Services

-- Fred L. Brown, F.A.C.H.E., Chairman of JCAHO's Board of Commissioners, Quovadx Director

-- Ronald A. Paulus, MD, MBA, Chief Healthcare Information Officer, Quovadx

Quovadx chief healthcare officer Dr. Ron Paulus, CareScience president Tom Zajac and speakers are available for interviews by appointment.

When: Sunday, March 13, 2005 - Wednesday March 16, 2005 The full agenda can be found online at: http://www.carescience.com/conference2005/agenda.html

Where: The Westin Mission Hills Resort and Spa Palm Springs, California

--30--PT/dx*

CONTACT: Quovadx, Inc. Andrea Lashnits, 720-554-1246 andrea.lashnits@quovadx.com

KEYWORD: CALIFORNIA PENNSYLVANIA INDUSTRY KEYWORD: INSURANCE PHARMACEUTICAL MEDICAL DEVICES MEDICAL TRADESHOW SOURCE: Quovadx, Inc.

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Quovadx Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Quovadx Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 735,12 1,30%